サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1595065

マイクロバイオーム・シーケンス・サービスの世界市場

Microbiome Sequencing Services

出版日
ページ情報
英文 193 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
マイクロバイオーム・シーケンス・サービスの世界市場
出版日: 2024年11月22日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 193 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

マイクロバイオーム・シーケンス・サービスの世界市場は2030年までに55億米ドルに達する

2023年に17億米ドルと推定されるマイクロバイオーム・シーケンス・サービスの世界市場は、分析期間2023-2030年にCAGR 18.1%で成長し、2030年には55億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである合成技術は、CAGR 16.8%を記録し、分析期間終了時には23億米ドルに達すると予測されます。ライゲーション技術分野の成長率は、分析期間のCAGRで14.7％と推定されます。

米国市場は4億7,620万米ドルと推定、中国はCAGR17.3％で成長予測

米国のマイクロバイオーム・シーケンス・サービス市場は、2023年に4億7,620万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに8億4,210万米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは17.3%です。その他の注目すべき地域別市場としては、日本とカナダがあり、それぞれ分析期間中に15.8%と15.5%のCAGRで成長すると予測されています。欧州では、ドイツがCAGR約13.2%で成長すると予測されています。

世界のマイクロバイオーム・シーケンス・サービス市場- 主要動向と促進要因のまとめ

マイクロバイオーム・シーケンス・サービスとは何か、なぜ現代のゲノミクスとヘルスケアにおいて重要なのか？

マイクロバイオーム・シーケンス・サービスは、人体、土壌、水、植物など様々な環境に存在する微生物群集を解析し、その特徴を明らかにするために、高度なシーケンス技術を使用します。これらのサービスにより、細菌、ウイルス、真菌、その他の微生物から構成されるマイクロバイオームの組成、多様性、機能に関する詳細な知見が得られます。16SrRNAシーケンス、ショットガンメタゲノミクス、ホールゲノムシーケンスなどの技術を用いて微生物の遺伝物質を解読し、健康、病気、農業、環境における微生物の役割を明らかにします。

マイクロバイオーム解析の重要性は、ヒトの健康、疾病予防、栄養、農業、生態系のバランスにおいて微生物が果たす重要な役割を明らかにする能力にあります。ヘルスケアでは、マイクロバイオーム解析によって個別化医療への道が開かれ、消化器疾患、代謝異常、自己免疫疾患、さらには精神疾患などの症状に対する標的療法の開発が可能になった。農業分野では、土壌の健康、作物の収穫量、植物の耐病性の向上に役立っています。マイクロバイオームへの理解が進むにつれ、調査は臨床研究と環境管理の両面で不可欠なツールになりつつあります。

技術の進歩はマイクロバイオーム・シーケンス・サービス市場をどのように形成しているか？

技術の進歩は、マイクロバイオーム・シーケンス・サービスの精度、スピード、費用対効果を大幅に向上させ、ヘルスケア、農業、環境科学におけるイノベーションを促進しています。主な進展の1つは、次世代シーケンサー（NGS）プラットフォームの採用であり、これはハイスループットで迅速なシーケンシング能力を低コストで提供します。Illuminaシーケンス、Oxford Nanoporeシーケンス、PacBioシーケンスなどのNGS技術は、微生物の多様性と機能に関する詳細な洞察を提供し、複雑なマイクロバイオームのより包括的な解析を可能にします。これにより、個別化医療、医薬品開発、診断におけるマイクロバイオームシーケンスの利用が拡大しました。

ショットガンメタゲノミクスの台頭は、マイクロバイオーム・シーケンス・サービスの能力をさらに向上させました。ターゲットを絞った16S rRNAシーケンスとは異なり、ショットガンメタゲノミクスではサンプル中のすべての遺伝物質をシーケンスするため、既知の種と新規の種の両方を含む微生物組成をより詳細に見ることができます。また、微生物の代謝経路や遺伝子発現プロファイルなど、機能的な洞察も得られます。これは、マイクロバイオームが健康や病気、生態系のバランスにどのように影響するかを理解する上で極めて重要です。この技術は、免疫調節、栄養吸収、薬物代謝における微生物の役割の解明に役立っており、臨床研究と治療開発の両方をサポートしています。

バイオインフォマティクスとデータ分析の進歩もマイクロバイオームシーケンス市場の形成に重要な役割を果たしています。強力なバイオインフォマティクスツールと機械学習アルゴリズムにより、研究者は大量のシーケンスデータを処理し、微生物分類群を同定し、機能的経路を予測し、マイクロバイオームプロファイルを特定の健康状態や環境パラメータと相関させることができるようになりました。これにより、複雑なマイクロバイオームデータの解釈が改善され、シーケンシングサービスがより実用的で、臨床、農業、生態学への応用に役立つものとなっています。さらに、クラウドベースのプラットフォームの開発により、マイクロバイオームデータの共有、保存、解析が容易になり、世界なコラボレーションとより効率的な研究が可能になりました。このような技術革新は、マイクロバイオーム・シーケンス・サービスの能力を拡大するだけでなく、精密医療、持続可能な農業、環境モニタリングといった幅広い動向にも合致しています。

様々な分野でのマイクロバイオーム・シーケンス・サービスの新たなアプリケーションとは？

マイクロバイオーム・シーケンス・サービスは、健康、病気、農業、環境の持続可能性における微生物の役割に対するより深い洞察の必要性によって、様々な分野での応用が拡大しています。ヘルスケア分野では、マイクロバイオームシークエンシングはヒトのマイクロバイオーム、特に腸、皮膚、口腔、呼吸器の研究に使用されています。これにより、過敏性腸症候群（IBS）、肥満、糖尿病、炎症性腸疾患（IBD）などの症状に対する個別化治療の開発が可能になります。腸内細菌叢の塩基配列を決定することで、プロバイオティクス、プレバイオティクス、食事介入で標的とすることができる有益な細菌を同定することができ、個別化された栄養と腸の健康管理をサポートします。

製薬業界では、マイクロバイオームのシーケンス解析が創薬や薬剤開発に利用されています。マイクロバイオームが薬物代謝や患者の反応にどのような影響を与えるかを分析することで、製薬会社はより的を絞った治療法を開発し、副作用を減らすことができます。このアプローチは、生きた細菌や微生物の代謝産物を使用してクロストリジウム・ディフィシル感染症、潰瘍性大腸炎、アトピー性皮膚炎などの疾患を治療する、マイクロバイオームベースの治療薬の開発において特に有用です。マイクロバイオームのシーケンス解析はまた、抗原として使用できる微生物成分を特定することでワクチン開発をサポートし、感染症予防に貢献します。

農業分野では、マイクロバイオームシークエンシングは、作物収量の向上、土壌の健康状態の改善、植物病害の生物防除剤の開発に利用されています。栄養吸収を促進し、植物の成長を促進し、病原性生物を抑制する有益な土壌微生物の同定に役立ちます。シークエンシングサービスにより、土壌や種子に添加して作物のパフォーマンスと回復力を向上させ、持続可能な農法をサポートする微生物コンソーシアムの作成が可能になります。環境分野では、マイクロバイオームのシーケンス解析は、土壌や水中の汚染物質の分解に微生物を利用するバイオレメディエーションの取り組みを支援します。また、汚染、気候変動、生息地の破壊などの要因による微生物の多様性の変化を分析することで、生態系のモニタリングもサポートします。このように、マイクロバイオームシーケンスの応用分野が拡大していることは、イノベーションを推進し、成果を改善し、人の健康と環境の両方における持続可能性をサポートする上で、マイクロバイオームシーケンスが重要な役割を担っていることを浮き彫りにしています。

マイクロバイオーム・シーケンス・サービス市場の成長の原動力は？

マイクロバイオーム・シーケンス・サービス市場の成長は、個別化医療に対する需要の増加、マイクロバイオーム研究に対する投資の増加、シーケンシングの技術的進歩など、いくつかの要因によってもたらされます。主な成長要因の1つは、ヒトマイクロバイオームへの関心の高まりと、その健康と疾患への影響です。マイクロバイオームの構成とさまざまな健康状態との関連性が解明されつつあることから、臨床と研究の両方の場面でマイクロバイオームシーケンスに対する需要が高まっています。この需要は、マイクロバイオームを標的とした治療や診断が精密医療の主流になりつつある腸の健康などの分野で特に強くなっています。

マイクロバイオーム研究への投資が増加していることが、シーケンスサービスの需要をさらに促進しています。政府、製薬会社、バイオテクノロジー企業はマイクロバイオームプロジェクトに多額の投資を行い、新薬、プロバイオティクス、診断ツールの開発を支援しています。さらに、抗菌薬耐性、腸の健康、代謝性疾患に焦点を当てた公衆衛生イニシアチブは、マイクロバイオーム研究への資金増加につながっており、微生物の詳細な洞察を提供するシーケンスサービスの需要を押し上げています。

シーケンス技術とバイオインフォマティクスの進歩も市場成長に寄与しています。ハイスループットでコスト効率の高いシーケンスプラットフォームの開発により、マイクロバイオームシーケンスが研究者、医療提供者、農業関連企業にとってより身近なものとなった。バイオインフォマティクスツールの改善により、複雑なマイクロバイオームデータの解釈が強化され、シーケンス結果を臨床、農業、環境アプリケーションのための実用的な洞察に変換することが容易になった。さらに、消費者向けマイクロバイオーム検査の台頭により、個人のマイクロバイオーム解析に対する一般の認識と関心が高まり、消費者の健康とウェルネスにおける市場の成長を支えています。

シーケンシング、データ解析、マイクロバイオームベースの治療法における技術革新が進む中、マイクロバイオーム・シーケンス・サービス市場は力強い成長を遂げようとしています。これらの動向は、精密医療、持続可能な農業、環境モニタリングに対する需要の高まりと相まって、マイクロバイオームシーケンスを、人間の健康増進、農業生産性の向上、さまざまな分野にわたる生態系バランスのサポートに焦点を当てた現代の科学戦略および臨床戦略に不可欠な要素にしています。

セグメント

用途（製薬、学術・研究機関、バイオテクノロジー）;技術（合成、ライゲーション、パイロシーケンス、サンガーシーケンス、その他の技術）

調査対象企業の例（注目の44社）

  • AnimalBiome
  • Arranta Bio
  • BIOHM
  • Biom Pharmaceutical Corporation
  • BioMathematica
  • BiomeSense
  • Biomesight
  • BIOMx
  • Biose Industry
  • Biotage AB

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP16589

Global Microbiome Sequencing Services Market to Reach US$5.5 Billion by 2030

The global market for Microbiome Sequencing Services estimated at US$1.7 Billion in the year 2023, is expected to reach US$5.5 Billion by 2030, growing at a CAGR of 18.1% over the analysis period 2023-2030. Synthesis Technique, one of the segments analyzed in the report, is expected to record a 16.8% CAGR and reach US$2.3 Billion by the end of the analysis period. Growth in the Ligation Technique segment is estimated at 14.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$476.2 Million While China is Forecast to Grow at 17.3% CAGR

The Microbiome Sequencing Services market in the U.S. is estimated at US$476.2 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$842.1 Million by the year 2030 trailing a CAGR of 17.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 15.8% and 15.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 13.2% CAGR.

Global Microbiome Sequencing Services Market - Key Trends & Drivers Summarized

What Are Microbiome Sequencing Services, and Why Are They So Crucial in Modern Genomics and Healthcare?

Microbiome Sequencing Services involve the use of advanced sequencing technologies to analyze and characterize the microbial communities found in various environments, including the human body, soil, water, and plants. These services provide detailed insights into the composition, diversity, and function of microbiomes, which consist of bacteria, viruses, fungi, and other microorganisms. Technologies like 16S rRNA sequencing, shotgun metagenomics, and whole-genome sequencing are used to decode the genetic material of microbes, uncovering their roles in health, disease, agriculture, and the environment.

The importance of microbiome sequencing lies in its ability to reveal the critical roles that microbes play in human health, disease prevention, nutrition, agriculture, and ecological balance. In healthcare, microbiome analysis has paved the way for personalized medicine, enabling the development of targeted therapies for conditions like gastrointestinal diseases, metabolic disorders, autoimmune diseases, and even mental health conditions. In agriculture, it helps improve soil health, crop yield, and plant disease resistance. As the understanding of microbiomes advances, microbiome sequencing services are becoming essential tools in both clinical research and environmental management.

How Are Technological Advancements Shaping the Microbiome Sequencing Services Market?

Technological advancements have significantly enhanced the accuracy, speed, and cost-effectiveness of Microbiome Sequencing Services, driving innovation across healthcare, agriculture, and environmental sciences. One of the major developments is the adoption of next-generation sequencing (NGS) platforms, which offer high-throughput, rapid sequencing capabilities at a lower cost. NGS technologies, including Illumina sequencing, Oxford Nanopore sequencing, and PacBio sequencing, provide detailed insights into microbial diversity and function, enabling more comprehensive analysis of complex microbiomes. This has expanded the use of microbiome sequencing in personalized medicine, drug development, and diagnostics.

The rise of shotgun metagenomics has further improved the capabilities of microbiome sequencing services. Unlike targeted 16S rRNA sequencing, shotgun metagenomics sequences all genetic material in a sample, allowing for a more detailed view of microbial composition, including both known and novel species. It also provides functional insights, such as microbial metabolic pathways and gene expression profiles, which are crucial for understanding how microbiomes influence health, disease, and ecological balance. This technology has been instrumental in uncovering microbial roles in immune modulation, nutrient absorption, and drug metabolism, supporting both clinical research and therapeutic development.

Advancements in bioinformatics and data analytics have also played a key role in shaping the microbiome sequencing market. Powerful bioinformatics tools and machine learning algorithms now enable researchers to process large volumes of sequencing data, identify microbial taxa, predict functional pathways, and correlate microbiome profiles with specific health conditions or environmental parameters. This has improved the interpretation of complex microbiome data, making sequencing services more actionable and valuable for clinical, agricultural, and ecological applications. Additionally, the development of cloud-based platforms has facilitated the sharing, storage, and analysis of microbiome data, enabling global collaboration and more efficient research. These technological innovations not only expand the capabilities of microbiome sequencing services but also align with broader trends toward precision medicine, sustainable agriculture, and environmental monitoring.

What Are the Emerging Applications of Microbiome Sequencing Services Across Different Sectors?

Microbiome Sequencing Services are finding expanding applications across various sectors, driven by the need for deeper insights into microbial roles in health, disease, agriculture, and environmental sustainability. In the healthcare sector, microbiome sequencing is used to study the human microbiome, particularly in the gut, skin, oral cavity, and respiratory tract. It enables the development of personalized treatments for conditions like irritable bowel syndrome (IBS), obesity, diabetes, and inflammatory bowel disease (IBD). Sequencing the gut microbiome helps identify beneficial bacteria that can be targeted with probiotics, prebiotics, and dietary interventions, supporting personalized nutrition and gut health management.

In the pharmaceutical industry, microbiome sequencing is used in drug discovery and development. By analyzing how microbiomes influence drug metabolism and patient response, pharmaceutical companies can develop more targeted therapies and reduce adverse drug reactions. This approach is particularly valuable in the development of microbiome-based therapeutics, which use live bacteria or microbial metabolites to treat conditions like Clostridioides difficile infection, ulcerative colitis, and atopic dermatitis. Microbiome sequencing also supports the development of vaccines by identifying microbial components that can be used as antigens, contributing to infectious disease prevention.

In the agriculture sector, microbiome sequencing is used to enhance crop yield, improve soil health, and develop biocontrol agents for plant diseases. It helps identify beneficial soil microbes that promote nutrient absorption, enhance plant growth, and suppress pathogenic organisms. Sequencing services enable the creation of microbial consortia, which are added to soil or seeds to improve crop performance and resilience, supporting sustainable farming practices. In the environmental sector, microbiome sequencing aids in bioremediation efforts, where microbes are used to break down pollutants in soil and water. It also supports ecosystem monitoring by analyzing changes in microbial diversity due to factors like pollution, climate change, and habitat destruction. The expanding applications of microbiome sequencing across these sectors highlight its critical role in driving innovation, improving outcomes, and supporting sustainability in both human health and the environment.

What Drives Growth in the Microbiome Sequencing Services Market?

The growth in the Microbiome Sequencing Services market is driven by several factors, including increasing demand for personalized medicine, rising investments in microbiome research, and technological advancements in sequencing. One of the primary growth drivers is the growing interest in the human microbiome and its impact on health and disease. As research continues to uncover links between microbiome composition and various health conditions, there is increasing demand for microbiome sequencing in both clinical and research settings. This demand is particularly strong in areas like gut health, where microbiome-targeted therapies and diagnostics are becoming mainstream in precision medicine.

Rising investments in microbiome research have further fueled demand for sequencing services. Governments, pharmaceutical companies, and biotechnology firms are investing heavily in microbiome projects, supporting the development of new drugs, probiotics, and diagnostic tools. In addition, public health initiatives focusing on antimicrobial resistance, gut health, and metabolic disorders have led to increased funding for microbiome studies, boosting demand for sequencing services that provide detailed microbial insights.

Advancements in sequencing technologies and bioinformatics have also contributed to market growth. The development of high-throughput, cost-effective sequencing platforms has made microbiome sequencing more accessible to researchers, healthcare providers, and agritech firms. Improved bioinformatics tools have enhanced the interpretation of complex microbiome data, making it easier to translate sequencing results into actionable insights for clinical, agricultural, and environmental applications. Additionally, the rise of direct-to-consumer microbiome testing has increased public awareness and interest in personal microbiome analysis, supporting market growth in consumer health and wellness.

With ongoing innovations in sequencing, data analytics, and microbiome-based therapeutics, the microbiome sequencing services market is poised for robust growth. These trends, combined with increasing demand for precision medicine, sustainable agriculture, and environmental monitoring, make microbiome sequencing a vital component of modern scientific and clinical strategies focused on improving human health, enhancing agricultural productivity, and supporting ecological balance across various sectors.

SCOPE OF STUDY:

The report analyzes the Microbiome Sequencing Services market in terms of US$ Thousand by the following End-Use; Technique, and Geographic Regions/Countries:

Segments:

End-Use (Pharmaceutical, Academic & Research Institutes, Biotech); Technique (Synthesis, Ligation, Pyrosequencing, Sanger Sequencing, Other Techniques)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 44 Featured) -

  • AnimalBiome
  • Arranta Bio
  • BIOHM
  • Biom Pharmaceutical Corporation
  • BioMathematica
  • BiomeSense
  • Biomesight
  • BIOMx
  • Biose Industry
  • Biotage AB

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Microbiome Sequencing Services - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Research on Gut Health Sets the Stage for Microbiome Analysis
    • Rising Incidences of Chronic Diseases Spur Demand for Microbiome Sequencing
    • Expanding Use in Cancer Research Generates Market Opportunities
    • Enhanced Accuracy and Speed of Sequencing Drives Adoption in Healthcare
    • Strong Investment in Genomics Research Crucial for Market Growth
    • Use in Drug Development Expands Microbiome Sequencing Market
    • Rising Demand for Functional Foods and Probiotics Propels Sequencing Adoption
    • Integration with AI for Predictive Analysis Strengthens Business Case
    • Expanding Applications in Dermatology Generate Demand for Sequencing Services
    • Growing Interest in Gut-Brain Axis Research Fuels Microbiome Sequencing Demand
    • Increasing Use in Nutrigenomics Generates Market Opportunities
    • Expanding Role in Infectious Disease Research Drives Sequencing Adoption
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Microbiome Sequencing Services Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Microbiome Sequencing Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World 7-Year Perspective for Microbiome Sequencing Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Synthesis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World 7-Year Perspective for Synthesis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Ligation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 7: World 7-Year Perspective for Ligation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Pyrosequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World 7-Year Perspective for Pyrosequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Sanger Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World 7-Year Perspective for Sanger Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Other Techniques by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 13: World 7-Year Perspective for Other Techniques by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Pharmaceutical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World 7-Year Perspective for Pharmaceutical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 17: World 7-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Biotech by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 19: World 7-Year Perspective for Biotech by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Microbiome Sequencing Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Microbiome Sequencing Services by Technique - Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 21: USA 7-Year Perspective for Microbiome Sequencing Services by Technique - Percentage Breakdown of Value Sales for Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques for the Years 2024 & 2030
    • TABLE 22: USA Recent Past, Current & Future Analysis for Microbiome Sequencing Services by End-Use - Pharmaceutical, Academic & Research Institutes and Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 23: USA 7-Year Perspective for Microbiome Sequencing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Academic & Research Institutes and Biotech for the Years 2024 & 2030
  • CANADA
    • TABLE 24: Canada Recent Past, Current & Future Analysis for Microbiome Sequencing Services by Technique - Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 25: Canada 7-Year Perspective for Microbiome Sequencing Services by Technique - Percentage Breakdown of Value Sales for Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques for the Years 2024 & 2030
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Microbiome Sequencing Services by End-Use - Pharmaceutical, Academic & Research Institutes and Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Canada 7-Year Perspective for Microbiome Sequencing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Academic & Research Institutes and Biotech for the Years 2024 & 2030
  • JAPAN
    • Microbiome Sequencing Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 28: Japan Recent Past, Current & Future Analysis for Microbiome Sequencing Services by Technique - Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 29: Japan 7-Year Perspective for Microbiome Sequencing Services by Technique - Percentage Breakdown of Value Sales for Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques for the Years 2024 & 2030
    • TABLE 30: Japan Recent Past, Current & Future Analysis for Microbiome Sequencing Services by End-Use - Pharmaceutical, Academic & Research Institutes and Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 31: Japan 7-Year Perspective for Microbiome Sequencing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Academic & Research Institutes and Biotech for the Years 2024 & 2030
  • CHINA
    • Microbiome Sequencing Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 32: China Recent Past, Current & Future Analysis for Microbiome Sequencing Services by Technique - Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: China 7-Year Perspective for Microbiome Sequencing Services by Technique - Percentage Breakdown of Value Sales for Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques for the Years 2024 & 2030
    • TABLE 34: China Recent Past, Current & Future Analysis for Microbiome Sequencing Services by End-Use - Pharmaceutical, Academic & Research Institutes and Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 35: China 7-Year Perspective for Microbiome Sequencing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Academic & Research Institutes and Biotech for the Years 2024 & 2030
  • EUROPE
    • Microbiome Sequencing Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 36: Europe Recent Past, Current & Future Analysis for Microbiome Sequencing Services by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 37: Europe 7-Year Perspective for Microbiome Sequencing Services by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2024 & 2030
    • TABLE 38: Europe Recent Past, Current & Future Analysis for Microbiome Sequencing Services by Technique - Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Europe 7-Year Perspective for Microbiome Sequencing Services by Technique - Percentage Breakdown of Value Sales for Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques for the Years 2024 & 2030
    • TABLE 40: Europe Recent Past, Current & Future Analysis for Microbiome Sequencing Services by End-Use - Pharmaceutical, Academic & Research Institutes and Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 41: Europe 7-Year Perspective for Microbiome Sequencing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Academic & Research Institutes and Biotech for the Years 2024 & 2030
  • FRANCE
    • Microbiome Sequencing Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 42: France Recent Past, Current & Future Analysis for Microbiome Sequencing Services by Technique - Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 43: France 7-Year Perspective for Microbiome Sequencing Services by Technique - Percentage Breakdown of Value Sales for Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques for the Years 2024 & 2030
    • TABLE 44: France Recent Past, Current & Future Analysis for Microbiome Sequencing Services by End-Use - Pharmaceutical, Academic & Research Institutes and Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: France 7-Year Perspective for Microbiome Sequencing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Academic & Research Institutes and Biotech for the Years 2024 & 2030
  • GERMANY
    • Microbiome Sequencing Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 46: Germany Recent Past, Current & Future Analysis for Microbiome Sequencing Services by Technique - Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 47: Germany 7-Year Perspective for Microbiome Sequencing Services by Technique - Percentage Breakdown of Value Sales for Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques for the Years 2024 & 2030
    • TABLE 48: Germany Recent Past, Current & Future Analysis for Microbiome Sequencing Services by End-Use - Pharmaceutical, Academic & Research Institutes and Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 49: Germany 7-Year Perspective for Microbiome Sequencing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Academic & Research Institutes and Biotech for the Years 2024 & 2030
  • ITALY
    • TABLE 50: Italy Recent Past, Current & Future Analysis for Microbiome Sequencing Services by Technique - Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Italy 7-Year Perspective for Microbiome Sequencing Services by Technique - Percentage Breakdown of Value Sales for Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques for the Years 2024 & 2030
    • TABLE 52: Italy Recent Past, Current & Future Analysis for Microbiome Sequencing Services by End-Use - Pharmaceutical, Academic & Research Institutes and Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 53: Italy 7-Year Perspective for Microbiome Sequencing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Academic & Research Institutes and Biotech for the Years 2024 & 2030
  • UNITED KINGDOM
    • Microbiome Sequencing Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 54: UK Recent Past, Current & Future Analysis for Microbiome Sequencing Services by Technique - Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 55: UK 7-Year Perspective for Microbiome Sequencing Services by Technique - Percentage Breakdown of Value Sales for Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques for the Years 2024 & 2030
    • TABLE 56: UK Recent Past, Current & Future Analysis for Microbiome Sequencing Services by End-Use - Pharmaceutical, Academic & Research Institutes and Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: UK 7-Year Perspective for Microbiome Sequencing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Academic & Research Institutes and Biotech for the Years 2024 & 2030
  • REST OF EUROPE
    • TABLE 58: Rest of Europe Recent Past, Current & Future Analysis for Microbiome Sequencing Services by Technique - Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 59: Rest of Europe 7-Year Perspective for Microbiome Sequencing Services by Technique - Percentage Breakdown of Value Sales for Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques for the Years 2024 & 2030
    • TABLE 60: Rest of Europe Recent Past, Current & Future Analysis for Microbiome Sequencing Services by End-Use - Pharmaceutical, Academic & Research Institutes and Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 61: Rest of Europe 7-Year Perspective for Microbiome Sequencing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Academic & Research Institutes and Biotech for the Years 2024 & 2030
  • ASIA-PACIFIC
    • Microbiome Sequencing Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 62: Asia-Pacific Recent Past, Current & Future Analysis for Microbiome Sequencing Services by Technique - Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Asia-Pacific 7-Year Perspective for Microbiome Sequencing Services by Technique - Percentage Breakdown of Value Sales for Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques for the Years 2024 & 2030
    • TABLE 64: Asia-Pacific Recent Past, Current & Future Analysis for Microbiome Sequencing Services by End-Use - Pharmaceutical, Academic & Research Institutes and Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 65: Asia-Pacific 7-Year Perspective for Microbiome Sequencing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Academic & Research Institutes and Biotech for the Years 2024 & 2030
  • REST OF WORLD
    • TABLE 66: Rest of World Recent Past, Current & Future Analysis for Microbiome Sequencing Services by Technique - Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 67: Rest of World 7-Year Perspective for Microbiome Sequencing Services by Technique - Percentage Breakdown of Value Sales for Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques for the Years 2024 & 2030
    • TABLE 68: Rest of World Recent Past, Current & Future Analysis for Microbiome Sequencing Services by End-Use - Pharmaceutical, Academic & Research Institutes and Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Rest of World 7-Year Perspective for Microbiome Sequencing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Academic & Research Institutes and Biotech for the Years 2024 & 2030

IV. COMPETITION